Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02296918 |
|---|---|
| Brief Title: | Acalabrutinib in Combination With Anti-CD20 and Venetoclax in Relapsed/Refractory or Untreated CLL/SLL/PLL |
| First Submitted : | November 19, 2014 |
| First Submitted that Met QC Criteria : | November 20, 2014 |
| First Posted : | November 21, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | September 17, 2019 |
| Last Update Posted : | September 18, 2019 |